Irene Schouten

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients

T. C. Linders, K. L. Ramkisoensing, D. van den Broek, 2022, Molecular oncology.